Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

, is included under the caption "Reconciliation of

Non-GAAP Measures".

Note 5: Includes interest income, interest expense and foreign exchange

gains and losses and other income and expenses not directly

attributable to Bunge's operating segments.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions)

(Unaudited)

December 31, December 31,

2007 2006

ASSETS

Current assets:

Cash and cash equivalents $981 $365

Trade accounts receivable 2,541 1,879

Inventories 5,924 3,684

Deferred income taxes 211 149

Other current assets 4,886 2,316

Total current assets 14,543 8,393

Property, plant and equipment, net 4,216 3,446

Goodwill 377 236

Other intangible assets, net 116 99

Investments in affiliates 706 649

Deferred income taxes 903 714

Other non-current assets 1,155 810

Total assets $22,016 $14,347

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Short-term debt $590 $454

Current portion of long-term debt 522 156

Trade accounts payable 4,061 2,328

Deferred income taxes 173 54

Other current liabilities 3,513 1,523

Total current liabilities 8,
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...n collaboration with the Chinese Academy of Scienc...tation of molecules on a fixed surface to understa...rotor-based machinery at nanoscale level. , The...ch play an important part in machines like electri...logy at the atomic scale is to replicate this prop...
...RCROSS, Ga., May 27 Immucor, Inc. (Nasdaq: BLUD...ent-reagent systems to the blood transfusion indus...r agreement with Alverno Clinical Laboratories, LL... integrated delivery systems in the nation, servin...r the agreement, Alverno is standardizing pre-tran...
...rst clinical study evaluating DUROS(R) continuous ...diabetes , , HAYWARD, Calif., May 27 Intarcia Th...linical data from a phase 1b study of ITCA 650 (DU...reatment of type 2 diabetes as a late-breaker at t...ciation in New Orleans, LA (June 5-9, 2009). The s...
Other Biology Technology:Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement 2Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 2Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 3
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Sakayu Shimizu of Kyoto University recipient of 2009 Enzyme Engineering Award 9960 1Sakayu Shimizu of Kyoto University recipient of 2009 Enzyme Engineering Award 9960 2Regulatory role of key molecule discovered at Hebrew U 9958 1MedTrust Online Surpasses 5 000 Registered Users and Adds Dr Henry Friedman to Oncology Advisory Board 14120 1MedTrust Online Surpasses 5 000 Registered Users and Adds Dr Henry Friedman to Oncology Advisory Board 14120 2
... scientists, including a team from The University ... (IMB), is a step closer to the next generation of...comprehensive analysis of the human and mouse tran...nd IMB researcher Professor David Hume said transc... the genome by a cell at any given time. , "Esse...
...rnational Rice Research Institute (IRRI) is workin...South East Asian Nations (ASEAN) to develop a seri... in the region. , When implemented, the indicators...e environmental impact of its rice production with...blems or improve on existing practices. It,s the f...
... isn,t really that sluggish after all. So says the...e creature,s behavior in the wild, which was just ...l Bulletin. , The new research is significant bec...dibranch mollusc species found in the shallow nort...of the how the brain controls behavior, a field kn...
Other Biology News:Learning the language of DNA 2A cleaner, greener rice industry 2The secret lives of sea slugs 2
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
...in filters allow for the rapid isolation of DNA fr...ice in the spin filter, centrifuge for 3 minutes, ...s no need to melt agarose or use any special buff...ange, primer removal from PCR reactions, and remov...
Human Atherosclerosis Antibody Array I Kit, ChemiArray, 20 cytokines per membrane from CHEMICON
High-Binding EIA 96 Well Strip Plates from Cayman Chemical
Biology Products: